Pfizer investing $350M in Chinese center

Pfizer Inc. (NYSE:PFE) is investing about $350 million to build the Pfizer Global Biotechnology Center in Hangzhou, China. The center, Pfizer's first in Asia, will focus on local production of biosimilars. Pfizer expects the center to be completed in 2018. ...